CDO1 and gastric cancer: We had developed pharmacologic reversal of epigenetic silencing and uncovered a myriad of transcriptionally repressed genes in human cancers [10–13], and have finally identified outstanding candidate TSG with frequent promoter DNA methylation, a cysteine dioxygenase type 1 (CDO1) gene in human cancers including gastric cancer [14].